Title:
Treatment of patients with relapsed or refractory CD19+ lym-phoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector A unicenter Phase I/II clinical trial
Phase:
I/II
Contact:
Beatrice Müller / Study Nurse
Email-Address:
Beatrice.Mueller@med.uni-heidelberg.de
Clinical Investigator:
Prof. Dr. Michael Schmitt
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT03676504
EudraCT-Number:
Siehe EU klinisches Studienregister
2016-004808-60